US Patent Issued to Cell Cure Neurosciences on April 7 for "Retinal pigment epithelium cell compositions" (Israeli Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,593,837, issued on April 7, was assigned to Cell Cure Neurosciences Ltd. (Israel).

"Retinal pigment epithelium cell compositions" was invented by Nir Netzer (Mazkeret Batya, Israel), Ofer Wiser (Jerusalem), Bat Shahaf (Jerusalem), Orit Gamburg (Modiin-Maccabim-Reut, Israel), Lior Rosenberg Belmaker (Jerusalem), Dana Hayoun Neeman (Kibbutz Nachshon, Israel) and Osnat Bohana Kashtan (Jerusalem).

According to the abstract* released by the U.S. Patent & Trademark Office: "Presented herein are ready to administer (RTA) retinal pigment epithelium (RPE) cell therapy compositions for the treatment of retinal degenerative diseases and injuries. A method of formulating human RPE cells for admi...